Drapkin Kimberlee C - Insider Non-Derivative Transactions at Jounce Therapeutics, Inc. (JNCE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 3, 2023, Drapkin Kimberlee C's relationship to Jounce Therapeutics, Inc. (JNCE) is Officer (President, CFO and Treasurer), and currently has 40,267 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other JNCE insiders.
Data Source: SEC.
Drapkin Kimberlee C - Insider Non-Derivative Transactions of JNCE Common Stock
Drapkin Kimberlee C - Insider Non-Derivative Transactions at JNCE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 4, 2023 | U -- (Common Stock) | 40267 | 0 | 0 |
| May 4, 2023 | U -- (Common Stock) | 25751 | 0 | 40267 |
| Jan 11, 2023 | Sell -- (Common Stock) | 7781 | 1.12 | 66018 |
| Jan 10, 2023 | Sell -- (Common Stock) | 6315 | 1.1 | 73799 |